Company Filing History:
Years Active: 2025
Title: Parikshit Dharampal Tyagi: Innovator in Influenza Vaccine Development
Introduction
Parikshit Dharampal Tyagi is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in creating innovative solutions for influenza prevention. His work is characterized by a focus on safety and efficacy in vaccine formulations.
Latest Patents
Parikshit holds a patent for a "Stabilized live attenuated influenza vaccine compositions." This patent outlines compositions and methods for manufacturing a live attenuated influenza vaccine (LAIV) that can be delivered intranasally. The LAIV composition is designed to provide protection against influenza virus infection. The strains used are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs). These strains contain the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. Notably, the LAIV strains are adapted to grow in Madin Darby canine kidney (MDCK) cells, avoiding the use of eggs in large-scale vaccine manufacturing. The purification process is streamlined, devoid of chromatography steps, and the composition includes one or more live attenuated influenza vaccine viruses without polymers and surfactants.
Career Highlights
Parikshit is currently associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His role involves research and development aimed at enhancing vaccine formulations and delivery methods. His innovative approach has positioned him as a key player in the field of immunology.
Collaborations
Parikshit collaborates with esteemed colleagues, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. Their combined expertise contributes to the advancement of vaccine technology and public health initiatives.
Conclusion
Parikshit Dharampal Tyagi's work in developing a stabilized live attenuated influenza vaccine represents a significant advancement in the field of immunization. His innovative contributions are vital for improving vaccine efficacy and accessibility, ultimately benefiting global health.